Haisco-usa Pharmaceuticals, Inc.
Clinical trials sponsored by Haisco-usa Pharmaceuticals, Inc., explained in plain language.
-
New sleep drug matches propofol in surgery trial
Symptom relief CompletedThis study tested a new medicine called HSK3486 to see if it works as well as propofol for putting adults to sleep before planned surgery. About 465 people took part. The goal was to safely and quickly achieve the right level of unconsciousness without needing extra rescue drugs.
Phase: PHASE3 • Sponsor: Haisco-USA Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 17, 2026 05:07 UTC
-
New anesthesia drug shows promise in phase 3 trial
Symptom relief CompletedThis study tested a new drug called HSK3486 to see if it works well for putting adults to sleep before planned surgery. About 255 people took part, and the drug was compared to a standard anesthesia drug, propofol. The main goal was to see how many people had a smooth and success…
Phase: PHASE3 • Sponsor: Haisco-USA Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
New sleep drug matches top anesthetic in surgery trial
Symptom relief CompletedThis study tested a new drug called HSK3486 to see if it works as well as the standard drug propofol for putting adults to sleep before planned surgery. About 400 people took part. The goal was to safely and effectively start general anesthesia without needing extra rescue drugs.
Phase: PHASE3 • Sponsor: Haisco-USA Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC
-
New sedative put to the test: will it be abused?
Knowledge-focused CompletedThis study looked at whether a new anesthetic drug called HSK3486 has potential for abuse. It involved 43 healthy adults who occasionally use depressants. Researchers compared HSK3486 to another anesthetic, propofol, to see how likely people are to misuse it.
Phase: PHASE1 • Sponsor: Haisco-USA Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 05:04 UTC
-
Heart check: new anesthetic put to the test in 48 healthy volunteers
Knowledge-focused CompletedThis completed Phase 1 study looked at whether a single dose of the anesthetic HSK3486 changes the heart's electrical activity (QTc interval) in 48 healthy adults aged 18 to 45. Participants received either HSK3486, a placebo, or a positive control drug, and their heart rhythms w…
Phase: PHASE1 • Sponsor: Haisco-USA Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 08, 2026 12:01 UTC